Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.42 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | GSK3B | P49841 | 2/20 | 0.39 |
| ▸ | ABCC8 | Q09428 | 1/20 | 0.39 |
| ▸ | KCNJ11 | Q14654 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | PARP1 | P09874 | 1/20 | 0.39 |
| ▸ | TDP2 | O95551 | 2/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CASP3 | P42574 | 2/20 | 0.38 |
| ▸ | ADK | P55263 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9453357 | 0.79 | SMN1; SMN2 (0.51) | POLBTDP1CYP3A4ALDH1A1SMN1; SMN2 | |
| SCHEMBL29236231 | 0.78 | ALDH1A1 (0.59) | POLBTDP1CYP3A4ALDH1A1HPRT1 | |
| SCHEMBL9503458 | 0.78 | CYP3A4 (0.51) | POLBTDP1CYP3A4SMN1; SMN2GSK3B | |
| SCHEMBL8092353 | 0.77 | ALDH1A1 (0.55) | POLBTDP1CYP3A4ALDH1A1SMN1; SMN2 | |
| SCHEMBL28138230 | 0.77 | CYP3A4 (0.46) | POLBTDP1CYP3A4ALDH1A1SMN1; SMN2 | |
| SCHEMBL9833098 | 0.75 | ALDH1A1 (0.62) | POLBTDP1CYP3A4ALDH1A1SMN1; SMN2 | |
| SCHEMBL135332 | 0.73 | GSK3B (0.56) | POLBALDH1A1GSK3BPARP1TDP2 | |
| SCHEMBL27307007 | 0.73 | ALDH1A1 (0.58) | POLBTDP1CYP3A4ALDH1A1SMN1; SMN2 | |
| SCHEMBL1767571 | 0.73 | ALDH1A1 (0.63) | POLBTDP1CYP3A4ALDH1A1HPRT1 | |
| SCHEMBL6785035 | 0.73 | GSK3B (0.45) | TDP1CYP3A4ALDH1A1SMN1; SMN2GSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108117505-A | A kind of preparation method for synthesizing diphenyl ether imidodicarbonic diamide | 杜庶铭 | 2018-06-05 | — | — | CN | claimed |
| US-20070043011-A1 | Substituted benzanilide compound and noxious organism controlling agent | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2007-02-22 | — | — | US | claimed |
| EP-1671941-A1 | SUBSTITUTED BENZANILIDE COMPOUND AND PEST CONTROL AGENT | Nissan Chemical Industries, Ltd. (JP) | 2006-06-21 | — | — | EP | claimed |
| US-20050250822-A1 | Substituted benzanilide compound and noxious organism controlling agent | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2005-11-10 | — | — | US | claimed |
| EP-1538138-A1 | SUBSTITUTED BENZANILIDE COMPOUND AND PEST CONTROL AGENT | NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) | 2005-06-08 | — | — | EP | claimed |
| CN-110483454-A | A kind of preparation method of two ether dianhydride of aromatic series | UNIV HUNAN NORMAL | 2019-11-22 | — | — | CN | disclosed |
| CN-108117505-A | A kind of preparation method for synthesizing diphenyl ether imidodicarbonic diamide | 杜庶铭 | 2018-06-05 | — | — | CN | disclosed |
| US-20070043011-A1 | Substituted benzanilide compound and noxious organism controlling agent | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2007-02-22 | — | — | US | disclosed |
| EP-1671941-A1 | SUBSTITUTED BENZANILIDE COMPOUND AND PEST CONTROL AGENT | Nissan Chemical Industries, Ltd. (JP) | 2006-06-21 | — | — | EP | disclosed |
| US-20050250822-A1 | Substituted benzanilide compound and noxious organism controlling agent | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2005-11-10 | — | — | US | disclosed |
| EP-1538138-A1 | SUBSTITUTED BENZANILIDE COMPOUND AND PEST CONTROL AGENT | NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) | 2005-06-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070043011-A1 | Substituted benzanilide compound and noxious organism controlling agent | L3MBTL1, L3MBTL3, L3MBTL4 | POLB 4797/4885TDP1 3260/4885CYP3A4 1420/4885 |
| US-20050250822-A1 | Substituted benzanilide compound and noxious organism controlling agent | GCN1, L3MBTL3, L3MBTL4 | POLB 4191/4885TDP1 3916/4885CYP3A4 1864/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.